ASP Isotopes (ASPI) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Adjusted EPS
- -$0.25
- Estimate
- -$0.39
- Surprise
- +35.9%
- Revenue (period 2026-06-30)
- $5.1M
- Score today
- 3.9/10
Revenue source: xbrl.
How the report landed
ASP Isotopes (ASPI) reported a narrower loss than forecast — adjusted EPS of -$0.25 against the -$0.39 estimate (a 35.9% beat on a still-unprofitable quarter).
Where TrendMatrix's rating stands now
TrendMatrix currently rates ASPI Hold at 3.9/10; no pre/post engine snapshot brackets this report.
2 of the last 4 quarters beat the estimate; this quarter's +35.9% surprise compares with a -33.1% four-quarter average. Next scheduled report: 2026-11-12.
What argues against it
- DATA_ISSUE: analyst_target_implausible (raw $13.00 vs price $2.21 — ratio 5.9×). Rejected, falling back to technical TP.
- Market cap $317M below $400M minimum
- Momentum score 3.0/10 — below 4.5 minimum
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $2.21
- Price target
- $3.25
- Stop
- $2.06
- Upside to target
- +47.1%
Risk check: RSI 29 — a level conventionally read as oversold; trading volume is running 1.5× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-10-16 — shown for context, not personalized investment advice.
ASPI at TrendMatrix's latest read
Materials producers report against the commodity cycle — realized-price capture and volume, not the EPS line, are the tells in a quarter like this.
- Industry
- Specialty Chemicals
- Market cap
- $317.4M
- P/E (fwd)
- -2.5
- 52-week range
- $2.05–$13.75
- Off 52-week high
- 83.9%
- RSI (14)
- 29
- Volume vs avg
- 1.50×
- Score today
- 3.9/10